RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma

Clinical trial NCT07114432 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07114432
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT Newly Diagnosed Multiple Myeloma (NDMM)

Start date: 2025-08-01
Primary completion: 2027-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.